Results 111 to 120 of about 178 (132)
Some of the next articles are maybe not open access.

Análisis costo-efectividad de Apixaban versus Enoxaparina en pacientes sometidos a reemplazo total de cadera o rodilla en Colombia

Revista Colombiana de Ortopedia y Traumatología, 2016
Resumen Introduccion El articulo trata de estimar la rentabilidad del apixaban frente a la enoxaparina para prevenir la tromboembolia venosa (TEV) en pacientes intervenidos de reemplazo total de cadera (THR) o reemplazo total de rodilla (TKR) en Colombia.
Jaime E. Ordóñez, Arlex U. Palacios
openaire   +1 more source

Cancer Statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Rebecca L Siegel, Kimberly D Miller
exaly  

Breast Cancer Statistics, 2022

Ca-A Cancer Journal for Clinicians, 2022
Hyuna Sung   +2 more
exaly  

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Ca-A Cancer Journal for Clinicians, 2018
Frank Bray   +2 more
exaly  

Cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Rebecca L Siegel   +2 more
exaly  

Global cancer statistics

Ca-A Cancer Journal for Clinicians, 2011
Frank Bray
exaly  

Cancer statistics, 2018

Ca-A Cancer Journal for Clinicians, 2018
Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2015

Ca-A Cancer Journal for Clinicians, 2015
Rebecca L Siegel
exaly  

Cancer statistics, 2013

Ca-A Cancer Journal for Clinicians, 2013
Ahmedin Jemal
exaly  

Cancer statistics, 2011

Ca-A Cancer Journal for Clinicians, 2011
Otis Brawley
exaly  

Home - About - Disclaimer - Privacy